PHASE-II TRIAL OF CISPLATIN AS 2-LINE CHEMOTHERAPY IN PATIENTS WITH ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA - A GYNECOLOGIC ONCOLOGY GROUP-STUDY

被引：74

作者：

THIGPEN, JT

BLESSING, JA

LAGASSE, LD

DISAIA, PJ

HOMESLEY, HD

机构：

[1] UNIV MISSISSIPPI,MED CTR,SCH MED,DEPT MED & OBSTET & GYNECOL,DIV MED ONCOL,JACKSON,MS 39216

[2] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,BUFFALO,NY 14263

[3] UNIV CALIF LOS ANGELES,SCH MED,DEPT OBSTET & GYNECOL,LOS ANGELES,CA 90024

[4] UNIV CALIF IRVINE,DEPT OBSTET & GYNECOL,IRVINE,CA 92717

[5] WAKE FOREST UNIV,BOWMAN GRAY SCH MED,GYNECOL ONCOL SECT,WINSTON SALEM,NC 27103

来源：

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1984年 / 7卷 / 03期

关键词：

D O I：

10.1097/00000421-198406000-00010

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：253 / 256

页数：4

共 11 条

[1]

DEVITA VT, 1976, CANCER-AM CANCER SOC, V38, P509, DOI 10.1002/1097-0142(197607)38:1<509::AID-CNCR2820380175>3.0.CO

[2]

2-A

[3]

GOTTLIEB JA, 1975, CANCER CHEMOTH REP 1, V59, P621

[4]

HAYES DM, 1977, CANCER, V39, P1372, DOI 10.1002/1097-0142(197704)39:4<1372::AID-CNCR2820390404>3.0.CO

[5]

2-J

[6]

HILL JM, 1975, CANCER CHEMOTH REP 1, V59, P647

[7]

ROSENBURG B, 1969, NATURE, V22, P385

[8]

THIGPEN T, 1981, CANCER, V48, P658, DOI 10.1002/1097-0142(19810715)48:1+<658::AID-CNCR2820481334>3.0.CO

[9]

2-R

[10]

THIGPEN T, 1979, CANCER TREAT REP, V63, P21